Lactobacillus fermentum market seen topping $1.2 billion by 2030

The global Lactobacillus fermentum market is projected to rise from $0.79 billion in 2025 to $1.22 billion by 2030, driven by demand for probiotics, functional foods and preventive health products. North America led in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - The Lactobacillus fermentum market is tied to broader demand for probiotics, digestive health and functional nutrition. - Growth in the category signals more spending on products aimed at gut health, immunity and preventive care. - The market’s long-term expansion also points to more room for nutraceuticals, supplements and fermentation-based innovation.

What happened: - The Business Research Company projected the global Lactobacillus fermentum market will grow from $0.79 billion in 2025 to $0.87 billion in 2026. - The report forecasts the market will reach $1.22 billion by 2030, implying a 9.0% CAGR over the period. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company also said its 2026 market reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables. - Download a free sample of the report. - View the full market report.

The details: - Lactobacillus fermentum is a probiotic bacterium found in the human digestive tract and in fermented foods. - The bacterium supports digestion, helps maintain a balanced gut microbiota and produces lactic acid that inhibits harmful bacteria. - The report said the market’s recent growth has been supported by fermented foods in diets, higher awareness of probiotic benefits, expansion in dairy fermentation, rising supplement use and more gastrointestinal problems. - Future growth is expected to be supported by demand for personalized nutrition, microbiome-based therapies, preventive healthcare, functional foods, clinical research into probiotics, nutraceuticals, supplements, fermentation technology and strain improvement. - The report identified probiotic-based personalized gut microbiome modulation, functional foods for immunity, microbiome profiling and bioinformatics-driven nutraceuticals, sustainable fermentation production methods and probiotics in preventive and clinical nutrition as key trends. - Functional foods and beverages are a major growth driver because they add bioactive ingredients beyond basic nutrition. - The report pointed to UK functional beverage data showing a 30% year-over-year increase in kombucha consumption and a 92% surge in health shots with ginger and turmeric in the week ending Feb. 22, 2025. - Rising gastrointestinal disorder rates are also lifting demand because Lactobacillus fermentum may help reduce bloating, diarrhea and inflammation by restoring microbial balance. - Crohn’s & Colitis Australia projected inflammatory bowel disease cases in Australia would rise from 20,511,881 in 2023 to 23,067,771 by 2030. - Vegan and plant-based diets are adding another layer of demand because consumers want help digesting fiber-rich foods and maintaining gut health. - Finder reported the UK vegan population grew from 1.4 million in 2023 to 2.5 million in 2024, equal to 2.5% of the population rising to 4.7%.

Between the lines: - The forecast suggests Lactobacillus fermentum is moving from a niche probiotic ingredient toward a broader platform for food, supplement and clinical nutrition products. - The strongest demand appears to come from consumers who want wellness benefits without pharmaceuticals. - The regional outlook implies mature demand in North America and faster adoption potential in Asia-Pacific, where functional foods and supplements may have more room to scale.

What's next: - The report expects the market to keep compounding through 2030 as personalized nutrition and microbiome science become more commercial. - Product development is likely to center on functional foods, precision nutraceuticals and probiotic formulations with clearer health positioning. - Expanded clinical research and fermentation improvements could shape which strains gain the most traction.

The bottom line: - Lactobacillus fermentum is emerging as a growth ingredient for the probiotic economy, with health-focused food and supplement trends doing much of the heavy lifting.